Allocation concealment appraisal of clinical therapy trials using the extended Composite Quality Score (CQS-2): An empirically based update (Protocol)
Résumé
Abstract Objectives: To revise CQS-2/Criterion II, concerning allocation concealment appraisal for prospective, controlled, clinical therapy trials. Methods: Meta-analyses of trials with inadequate allocation concealment will be tested for in-between trial heterogeneity (I2 > 0) due to imbalances in baseline variables. Meta-analyses with positive test results will be used as basis to infer criteria for adequate allocation concealment. The CQS-2/Criterion II will be reformulated in line with the findings. The revised appraisal tool will be specified as CQS-2B Reporting: The final report will be made available online as preprint in one of the major preprint repositories and submitted to a peer-reviewed journal.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 10/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →